| A Phase II Trial of Ridaforolimus and Exemestane, Compared to Ridaforolimus, Dalotuzumab and Exemestane in Participants With Breast Cancer (MK-8669-064) (NCT01605396) | Merck Sharp & Dohme LLC | 2012-07-04 |
| Health Benefits of Expressive Writing Among Chinese Breast Cancer Survivors (NCT02946619) | University of Houston | 2012-06-01 |
| Photography or Video in Assessing Breast Reconstruction? (NCT01547338) | NHS Greater Glasgow and Clyde | 2012-06-01 |
| Nurse-led Care Program for Cancer Patients in Chemotherapy Day Center (NCT02228200) | The Hong Kong Polytechnic University | 2012-06-01 |
| A Study of Pertuzumab in Combination With Trastuzumab (Herceptin) and a Taxane in First-Line Treatment in Participants With Human Epidermal Growth Factor 2 (HER2)-Positive Advanced Breast Cancer (NCT01572038) | Hoffmann-La Roche | 2012-06-01 |
| Phase III Study Comparing the Efficacy and Safety of LA-EP2006 and Neulasta® (NCT01735175) | Sandoz | 2012-06-01 |
| A Safety and Tolerability Study of Assisted and Self-Administered Subcutaneous (SC) Herceptin (Trastuzumab) as Adjuvant Therapy in Early Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer (NCT01566721) | Hoffmann-La Roche | 2012-05-17 |
| Living Conditions and Breast Cancer (NCT01626950) | Centre Hospitalier Universitaire de Nīmes | 2012-05-01 |
| Letrozole and Lapatinib Followed by Everolimus in Women With Advanced Breast Cancer (NCT01499160) | University of Maryland, Baltimore | 2012-05-01 |
| Nodal Staging in Breast Cancer With MRL (NCT01609920) | Maastricht University Medical Center | 2012-05-01 |
| A Study of Famitinib Malate in HER2-negative Metastatic Breast Cancer (NCT01653574) | Fudan University | 2012-05-01 |
| Night-time Compression Systems for Breast Cancer Related Lymphedema (NCT01550250) | University of Alberta | 2012-04-01 |
| The Effects of Circadian Gene on Sleep and Associated Symptoms in Breast Cancer Patients Under Chemotherapy (NCT01887925) | Seoul National University Hospital | 2012-02-01 |
| Digital Breast Tomosynthesis Versus Digital Mammography: A National Multicenter Trial (NCT01524029) | Medical University of Vienna | 2012-01-01 |
| Trial of Eribulin Followed by Doxorubicin & Cyclophosphamide for Her2-negative, Locally Advanced Breast Cancer (NCT01498588) | Emory University | 2011-11-01 |
| Imaging Study for FdCyd and THU Cancer Treatment (NCT01479348) | National Cancer Institute (NCI) | 2011-11-01 |
| A Study of Apatinib in Non-triple-negative Metastatic Breast Cancer (NCT01653561) | Fudan University | 2011-11-01 |
| Lux-Breast 3; Afatinib Alone or in Combination With Vinorelbine in Patients With Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer Suffering From Brain Metastases (NCT01441596) | Boehringer Ingelheim | 2011-10-01 |
| The Use of Botulinum Toxin A in Two-Stage Tissue Expander/ Implant Breast Reconstruction (NCT01427400) | University of British Columbia | 2011-10-01 |
| Participant Preference of Subcutaneous (SC) Versus Intravenous (IV) Herceptin (Trastuzumab) in Human Epidermal Growth Factor Receptor (HER) 2-Positive Early Breast Cancer (NCT01401166) | Hoffmann-La Roche | 2011-10-01 |
| Gadofosveset for Axillary Staging in Breast Cancer Patients (NCT01437865) | Maastricht University Medical Center | 2011-09-01 |
| Comparison Study of Sentinel Lymph Node Biopsy by Multimodal Method in Breast Cancer (NCT01856452) | National Cancer Center, Korea | 2011-09-01 |
| Decision Support for Women With Breast Cancer (NCT01447771) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2011-09-01 |
| Chloroquine With Taxane Chemotherapy for Advanced or Metastatic Breast Cancer After Anthracycline Failure (CAT) (NCT01446016) | The Methodist Hospital Research Institute | 2011-09-01 |
| Genomic Signatures to Predict Treatment Response (NCT02032745) | Medical University of Graz | 2011-08-01 |
| A Novel Prosocial Online Support Group for Distressed Breast Cancer Survivors (NCT01396174) | Temple University | 2011-08-01 |
| Pilot Imaging Study With 89Zr-Trastuzumab in HER2-positive Metastatic Breast Cancer Patients (NCT01420146) | Jules Bordet Institute | 2011-08-01 |
| Afatinib (BIBW2992) in HER2 (Human Epidermal Growth Factor Receptor 2)-Overexpressing Inflammatory Breast Cancer (NCT01325428) | Boehringer Ingelheim | 2011-08-01 |
| Diffuse Optical Tomography (DOT) for Monitoring Response to Neoadjuvant (Preoperative) Chemotherapy in Breast Cancer (NCT01394315) | National Cancer Centre, Singapore | 2011-08-01 |
| BRCA Mutations in Latinas (NCT01251900) | National Cancer Institute (NCI) | 2011-07-07 |
| The Ultrasound Study of Tamoxifen (NCT01582074) | National Cancer Institute (NCI) | 2011-07-05 |
| Safety Study of ²¹²Pb-TCMC-Trastuzumab Radio Immunotherapy (NCT01384253) | Orano Med LLC | 2011-07-01 |
| Study of Aspirin and Exemestane as Adjuvant Treatment in Breast Cancer (NCT01431053) | Chinese Academy of Medical Sciences | 2011-07-01 |
| Study of Chemotherapy With Adoptive Cellular Therapy With DC-CIK Cells in Triple Negative Breast Cancer Patients (NCT01395056) | Peking University Cancer Hospital & Institute | 2011-07-01 |
| Bone Loss Treatment From Adjuvant Zoledronate Efficacy (NCT01623908) | First Affiliated Hospital, Sun Yat-Sen University | 2011-07-01 |
| LUX-Breast 2; Afatinib in HER2 (Human Epidermal Growth Factor Receptor)-Treatment Failures (NCT01271725) | Boehringer Ingelheim | 2011-05-24 |
| Tolerability of the Combination of Lapatinib and Trastuzumab in Adults Age 60 or Older With HER2 Positive Locally Advanced or Metastatic Breast Cancer (NCT01273610) | City of Hope Medical Center | 2011-04-20 |
| Aromasin® As Adjuvant Treatment In Postmenopausal Women With Invasive, Estrogen Receptor Positive Early Breast Cancer (NCT01239745) | Pfizer | 2011-04-01 |
| Early Detection of Cancers in Low Resource Countries (NCT01178736) | Woman's Cancer Foundation | 2011-03-01 |
| Aromasin® Interventional Study Of Early Invasive Breast Cancer Patients In China (NCT01176916) | Pfizer | 2011-02-09 |
| Nuevo Amanecer: Promoting the Psychosocial Health of Latinas (NCT01383174) | University of California, San Francisco | 2011-02-01 |
| Neoadjuvant Platinum-based Chemoradiation Therapy for Locally Advanced Triple Negative Breast Cancer (NCT01167192) | Washington University School of Medicine | 2011-02-01 |
| A Pilot Study of Tumor-Derived Exosomes as Diagnostic and Prognostic Markers in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy (NCT01344109) | Leo W. Jenkins Cancer Center | 2011-02-01 |
| Comparison of Full-Field Digital Mammography With Digital Breast Tomography for Screening Call-Back Rates (NCT01236781) | American College of Radiology | 2011-01-04 |
| Study of Talazoparib, a PARP Inhibitor, in Patients With Advanced or Recurrent Solid Tumors (NCT01286987) | Pfizer | 2011-01-03 |
| Potential Benefits of Radiotherapy in Prone Position for Breast Cancer Patients: a Planning Study (NCT01284153) | Universitaire Ziekenhuizen KU Leuven | 2011-01-01 |
| A Study Inhibiting Telomerase to Reverse Trastuzumab Resistance in HER2+ Breast Cancer (NCT01265927) | Indiana University | 2011-01-01 |
| Prospective Phase II Study of Intraoperative Radiotherapy (IORT) in Elderly Patients with Small Breast Cancer (NCT01299987) | Universitätsmedizin Mannheim | 2011-01-01 |
| Bevacizumab With Etoposide and Cisplatin in Breast Cancer Patients With Brain and/or Leptomeningeal Metastasis (NCT01281696) | National Taiwan University Hospital | 2011-01-01 |
| Randomized Phase II Trial of Anastrozole Plus Metronomic Tegafur-uracil as Neo-adjuvant Therapy in Postmenopausal Breast Cancer (NCT01262274) | Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan | 2010-12-01 |
| A Study of Lapatinib in Combination With Everolimus in Patients With Advanced, Triple Negative Breast Cancer (NCT01272141) | Emory University | 2010-12-01 |
| Screening MRI for Cancer Recurrence in Patients Treated With Breast Conserving Therapy (NCT01257152) | Seoul National University Hospital | 2010-12-01 |
| Clinical Evaluation of OSNA Breast Cancer System in Breast Cancer Patients Receiving Neoadjuvant Therapy (NCT01140776) | Sysmex America, Inc. | 2010-11-01 |
| Gene Expression Profiling of Breast Cancer Cells Predict the Response of Malignant Pleural Effusion (NCT01256801) | Peking University Cancer Hospital & Institute | 2010-11-01 |
| Persistent Pain After Breast Cancer Treatment With Docetaxel (NCT01279018) | Rigshospitalet, Denmark | 2010-10-01 |
| Ultrasound vs. Predetermined Distance Techniques for Paravertebral Nerve Block in Patients Having Breast Surgery (NCT01217593) | Ochsner Health System | 2010-10-01 |
| Study of High-dose Chemotherapy (HDC) Combined With Adoptive Cellular Therapy With DC-CIK Cells in Triple Negative Breast Cancer Patients (NCT01232062) | Peking University Cancer Hospital & Institute | 2010-08-01 |
| Study the Role of Stem Cell in Curing Drug Induced Liver Injury in Metastatic Breast Cancer (MBC) (NCT01231022) | Peking University Cancer Hospital & Institute | 2010-08-01 |
| Sweden Cancerome Analysis Network - Breast : Genomic Profiling of Breast Cancer (NCT02306096) | Lund University | 2010-08-01 |
| Gene Expression Profiling of Metastatic Breast Cancer Predict the Therapeutic Response to Chemotherapy (NCT01198301) | Peking University Cancer Hospital & Institute | 2010-08-01 |
| Re-expression of ER in Triple Negative Breast Cancers (NCT01194908) | Emory University | 2010-07-01 |
| Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer (NCT01151215) | AstraZeneca | 2010-06-01 |
| Quality of Life in Breast Cancer Patients and Survivors (NCT01272401) | University of Illinois at Urbana-Champaign | 2010-06-01 |
| MM-111 in Combination With Herceptin in Patients With Advanced Her2 Amplified, Heregulin Positive Breast Cancer (NCT01097460) | Merrimack Pharmaceuticals | 2010-04-01 |
| I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer (NCT01042379) | QuantumLeap Healthcare Collaborative | 2010-03-01 |
| Clinical Evaluation of OSNA Breast Cancer System to Extensive Frozen Section Histopathology (NCT01368744) | Sysmex America, Inc. | 2010-03-01 |
| A Phase I Safety Study of a Cancer Vaccine to Treat HLA-A2 Positive Advanced Stage Ovarian, Breast and Prostate Cancer (NCT01095848) | ImmunoVaccine Technologies, Inc. (IMV Inc.) | 2010-03-01 |
| Breast Cancer and Exercise Trial in Alberta (NCT01435005) | AHS Cancer Control Alberta | 2010-03-01 |
| Study of XL147 (SAR245408) in Combination With Trastuzumab or Paclitaxel and Trastuzumab in Subjects With Metastatic Breast Cancer Who Have Progressed on a Previous Trastuzumab-based Regimen (NCT01042925) | Sanofi | 2010-02-01 |
| Impact of Acceptance and Commitment Therapy on Early Stage Breast Cancer (NCT01164930) | San Jose State University | 2010-01-01 |
| A Randomized Trial Comparing EC-wPversus EP-wP as Adjuvant Therapy for Operable Breast Cancer Patients Less Than 40 Years Old (NCT01026116) | Fudan University | 2009-12-01 |
| Everolimus in Breast Cancer Patients After Pre-operative Chemotherapy (NCT01088893) | Organisation for Oncology and Translational Research | 2009-11-01 |
| Figitumumab Combined With Pegvisomant For Advanced Solid Tumors (NCT00976508) | Pfizer | 2009-11-01 |
| Study to Evaluate Markers of Response in Locally Advanced Breast Cancer (NCT01338753) | Clinica Universidad de Navarra, Universidad de Navarra | 2009-10-01 |
| Delaying the Superficial Inferior Epigastric Artery (SIEA) Flap and Determining the Change in SIEA Diameter and Blood Flow (NCT01247129) | University Medical Centre Ljubljana | 2009-09-01 |
| A Multi-Histology Phase II Study of 5-Fluoro-2'-Deoxycytidine With Tetrahydrouridine (FdCyd + THU) (NCT00978250) | National Cancer Institute (NCI) | 2009-08-20 |
| Phase I Open Label Trial to Assess Safety of BIBW 2992 (Afatinib) in Combination With Herceptin® in Patients With HER2-positive Advanced Breast Cancer. (NCT00950742) | Boehringer Ingelheim | 2009-08-01 |
| Positron Emission Mammography With Fluorothymidine (FLT) to Evaluate Treatment Response to Chemotherapy in Breast Cancer (NCT00934401) | University of Iowa | 2009-07-01 |
| Comparative Analysis of the Efficacies in Neoadjuvant Chemotherapy of Breast Cancer (NCT02613026) | 307 Hospital of PLA | 2009-07-01 |
| Phase I/II AZD8931/Paclitaxel in Treatment of Advanced Solid Tumours (Phase I) and Advanced Breast Cancer (Phase II) (NCT00900627) | AstraZeneca | 2009-06-01 |
| Prevalence of Genetic Polymorphisms in Genes Coding for Tamoxifen Metabolising Enzymes (NCT00966043) | Vlaamse Vereniging voor Obstetrie en Gynaecologie | 2009-06-01 |
| Imiquimod for Breast Cancer Patients With Chest Wall Recurrence or Skin Metastases (NCT00899574) | NYU Langone Health | 2009-05-01 |
| Evaluating the T Cell Response to a Peptide-based Vaccine in Patients With Breast Cancer (NCT00892567) | Craig L Slingluff, Jr | 2009-05-01 |
| Trial Using Docetaxel Cytoxan in Breast Cancers With High Recurrence Scores (NCT00832338) | Emory University | 2009-04-01 |
| Heading Off Peripheral Neuropathy With Exercise (NCT00869804) | University of Nebraska | 2009-03-25 |
| Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer (NCT00807859) | Amgen | 2009-03-09 |
| CYP19 Genetic Polymorphism & Aromatase Inhibitor(AI) (NCT00973505) | Korea University Anam Hospital | 2009-03-01 |
| A Registry Study of Permanent Breast Seed Implant (NCT01106521) | Sunnybrook Health Sciences Centre | 2009-03-01 |
| CYP2D6 Genotype on the Clinical Effect of Tamoxifen (NCT00973037) | Korea University Anam Hospital | 2009-03-01 |
| Women Underwent TRAM Surgery: Its Influence on Abdominal Muscle Function and the Effects of Therapeutic Exercises (NCT04886921) | Kaohsiung Medical University Chung-Ho Memorial Hospital | 2009-02-24 |
| Study to Investigate Adherence of Patients to Clodronate (Bonefos) Treatment (NCT01198457) | Bayer | 2009-01-01 |
| 6 Weeks Treatment of Locally Advanced Breast Cancer With BIBW 2992 (Afatinib) or Lapatinib or Trastuzumab (NCT00826267) | Boehringer Ingelheim | 2009-01-01 |
| An Observational Study Of Indian Breast Cancer Patients Receiving Adjuvant Therapy With Aromasin (NCT00776659) | Pfizer | 2008-12-01 |
| Calcitriol, Physical Activity, and Bone Health in Cancer Survivors (NCT00904033) | University of Rochester | 2008-12-01 |
| Trial of Low Dose Tamoxifen in Women With Breast Intraepithelial Neoplasia - Long Term Follow-up (NCT01357772) | Andrea DeCensi | 2008-11-12 |
| Elective Internal Mammary Node Irradiation in Women With Node-positive Breast Cancer (NCT04803266) | Yonsei University | 2008-11-05 |
| A Pilot Trial of Itraconazole Pharmacokinetics in Patients With Metastatic Breast Cancer (NCT00798135) | Indiana University | 2008-11-01 |
| Effects of Rapid Genetic Counseling and Testing in Newly Diagnosed Breast Cancer Patients (NCT00783822) | The Netherlands Cancer Institute | 2008-11-01 |
| Study of AVE1642 (IGF-1R/CD221) in Combination With Fulvestrant (Faslodex®) in Postmenopausal Patients With Advanced Hormono-dependent Breast Cancer (NCT00774878) | Sanofi | 2008-10-01 |
| Oral Deforolimus With Trastuzumab for Patients With HER2-positive Trastuzumab-Refractory Metastatic Breast Cancer (8669-009) (NCT00736970) | Merck Sharp & Dohme LLC | 2008-07-01 |